Aptevo Therapeutics, Inc. (NASDAQ: APVO) Starts Presentation at 29th Annual ROTH Conference
Aptevo Therapeutics (NASDAQ: APVO) is a biotechnology company based in Seattle, Washington focused on novel oncology and hematology therapeutics to meaningfully improve patients’ lives. The company’s core technology is the ADAPTIR™ (modular protein technology) platform. Aptevo has four commercial products in the areas of hematology and infectious diseases, as well as various investigational stage product candidates in immuno-oncology. For more information, visit the company’s website at www.aptevotherapeutics.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of…







